Partnership
PET is proud to be an independent, efficient and well-run charity, we have a reputation for punching well above our weight. We are fortunate that we have a large and engaged group of volunteers to help us, but for financial support we rely on donations, grants and corporate partners.
Have you or your organisation considered partnering with PET? If so, we understand that our partners will have different goals, so we’ll work hard to understand those goals and how PET can help attain them in a mutually beneficial partnership. It might be that support is financial or it could be in-kind (for example, use of a venue or professional advice). You may want to take a long-term, organic approach to the partnership or a more transactional short-term sponsorship arrangement.
Whatever the nature of the partnership, tangible benefits could include reciprocal PR, exposure to PET’s audience (healthcare professionals, lawyers, scientists, academics, policymakers and researchers), content creation and access to PET’s expertise (in running events and online publishing). The intangible benefits are equally powerful: for example, connection to an engaged and well-defined community in the genomics, fertility and embryo and stem cell research fields.
If you or your organisation are interested in collaborating with us on events, projects or initiatives, please contact us.
Sponsorship
Through BioNews, we successfully combine accurate science reporting with opinion and comment on developments in the fields of genomics, assisted reproduction and embryo/stem cell research. BioNews is highly regarded by eminent figures in these fields.
Dr Jane Stewart, former Chair of the British Fertility Society, says:
'BioNews is always current, not afraid to be provocative or controversial but always with an eye to evidence. As a "free" publication it excels. I would advise all those working in our field of reproductive medicine to subscribe'
Professor Anneke Lucassen, former Chair of the British Society for Genetic Medicine, says:
'PET continues to inform debate on genetics, genomics and assisted conception, via its free flagship publication BioNews. Through news, comments and review articles, scientists, clinicians, journalists and anyone interested, can stay abreast of recent developments in this area.'
By entering a sponsorship arrangement with PET individuals, businesses, research councils and grant giving bodies have the opportunity to forge links with an audience of academics, clinicians, ethicists, lawyers, nurses, patients, policymakers, politicians, researchers, scientists, sociologists, students, support groups and an interested broader public.
We have a variety of sponsorship opportunities and packages available, which can be tailored to meet sponsors' objectives and budgets. By entering a sponsorship arrangement with us, you can enjoy a wide range of benefits which can:
- Raise your brand awareness and create preference;
- Provide attractive content for a range of your products and services;
- Build your brand positioning through associative imagery;
- Support a sales promotion campaign;
- Create internal emotional commitment to your brand.
Opportunities include:
- Sponsoring an event or other initiative organised by PET.
- Sponsoring an edition or section of the BioNews newsletter.
We work in close partnership with our sponsors, and we welcome ideas that would enhance the relationship for both parties. Where possible, we endeavour to involve our sponsors directly in our projects and programmes over a number of years, to ensure that the sponsor develops a personal relationship with a project and a sense of stewardship.
If you or your organisation are interested in sponsoring our work, please contact us.
Consultancy
Our team is extremely knowledgeable about PET's subject area and the policy landscape, and is often called upon to advise or give presentations on topics ranging from the state of the fertility sector to the science, ethics and regulation of genome editing.
If you are interested in commissioning one of our team, please contact us.